Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients,and Cryoport, Inc., a temperature-controlled logistics solutions company serving the life sciences industry, announced a 3-year agreement to ensure safe and fully monitored transport of Adaptimmune’s cell therapies.
This agreement with Cryoport will contribute to optimizing manufacturing and supply operations and other solutions, including investment in the latest systems and technology, digitization of the supply chain information, and improved communications with patients and healthcare professionals.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.